Tianjin Chase Sun Pharmaceutical Co Ltd (300026):企業の財務・戦略的SWOT分析

◆英語タイトル:Tianjin Chase Sun Pharmaceutical Co Ltd (300026) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH309176FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tianjin Chase Sun Pharmaceutical Co Ltd (Chase Sun) is a medicine and health industry group. The company research, develops, produces, and markets various pharmaceutical products. It offers products such as Chinese herb preparations, Chinese medicinal granules, synthetic drugs, biotech drugs, medical apparatus and internet based therapy, among others. Chase Sun also produces synthetic drugs and preparation products such as polysaccharides, peptides, anti-cancer drugs, and other drugs. The company also provides research and development services. It conducts research programs for the treatment of sepsis, pulmonary hypertension, cardiovascular disease, ischemic stroke, HCV, vascular disease, psychosis, chemotherapy, and others. Chase Sun is headquartered in Tianjin, China.

Tianjin Chase Sun Pharmaceutical Co Ltd Key Recent Developments

Feb 25,2021: Hongri Pharmaceutical won the title of National Advanced Group for Poverty Alleviation
Jan 21,2021: Hongri Pharmaceutical won the AAA credit rating of 2020 pharmaceutical industry enterprises
Aug 17,2020: Starpharma signs new DEP partnership with Chase Sun

This comprehensive SWOT profile of Tianjin Chase Sun Pharmaceutical Co Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Tianjin Chase Sun Pharmaceutical Co Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Tianjin Chase Sun Pharmaceutical Co Ltd – Key Information
Tianjin Chase Sun Pharmaceutical Co Ltd – Overview
Tianjin Chase Sun Pharmaceutical Co Ltd – Key Employees
Tianjin Chase Sun Pharmaceutical Co Ltd – Key Employee Biographies
Tianjin Chase Sun Pharmaceutical Co Ltd – Key Operational Heads
Tianjin Chase Sun Pharmaceutical Co Ltd – Major Products and Services
Tianjin Chase Sun Pharmaceutical Co Ltd – History
Tianjin Chase Sun Pharmaceutical Co Ltd – Company Statement
Tianjin Chase Sun Pharmaceutical Co Ltd – Locations And Subsidiaries
Tianjin Chase Sun Pharmaceutical Co Ltd
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Tianjin Chase Sun Pharmaceutical Co Ltd – Business Description
Tianjin Chase Sun Pharmaceutical Co Ltd – Corporate Strategy
Tianjin Chase Sun Pharmaceutical Co Ltd – SWOT Analysis
SWOT Analysis – Overview
Tianjin Chase Sun Pharmaceutical Co Ltd – Strengths
Tianjin Chase Sun Pharmaceutical Co Ltd – Weaknesses
Tianjin Chase Sun Pharmaceutical Co Ltd – Opportunities
Tianjin Chase Sun Pharmaceutical Co Ltd – Threats
Tianjin Chase Sun Pharmaceutical Co Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Tianjin Chase Sun Pharmaceutical Co Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Tianjin Chase Sun Pharmaceutical Co Ltd, Key Information
Tianjin Chase Sun Pharmaceutical Co Ltd, Key Ratios
Tianjin Chase Sun Pharmaceutical Co Ltd, Share Data
Tianjin Chase Sun Pharmaceutical Co Ltd, Major Products and Services
Tianjin Chase Sun Pharmaceutical Co Ltd, History
Tianjin Chase Sun Pharmaceutical Co Ltd, Key Employees
Tianjin Chase Sun Pharmaceutical Co Ltd, Key Employee Biographies
Tianjin Chase Sun Pharmaceutical Co Ltd, Key Operational Heads
Tianjin Chase Sun Pharmaceutical Co Ltd, Other Locations
Tianjin Chase Sun Pharmaceutical Co Ltd, Subsidiaries
Tianjin Chase Sun Pharmaceutical Co Ltd, Key Competitors
Tianjin Chase Sun Pharmaceutical Co Ltd, SWOT Analysis
Tianjin Chase Sun Pharmaceutical Co Ltd, Ratios based on current share price
Tianjin Chase Sun Pharmaceutical Co Ltd, Annual Ratios
Tianjin Chase Sun Pharmaceutical Co Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Tianjin Chase Sun Pharmaceutical Co Ltd (300026):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • New York & Company, Inc.:企業の戦略・SWOT・財務情報
    New York & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary New York & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Kangwon Land Inc.
    Kangwon Land Inc. - Strategy, SWOT and Corporate Finance Report Summary Kangwon Land Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • K.P.R. Mill Ltd:企業の戦略・SWOT・財務情報
    K.P.R. Mill Ltd - Strategy, SWOT and Corporate Finance Report Summary K.P.R. Mill Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Worthington Industries Inc:戦略・SWOT・企業財務分析
    Worthington Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Worthington Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • IFA Hotels and Resorts Company KSCC:企業の戦略・SWOT・財務情報
    IFA Hotels and Resorts Company KSCC - Strategy, SWOT and Corporate Finance Report Summary IFA Hotels and Resorts Company KSCC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Dawnrays Pharmaceutical (Holdings) Ltd (2348):企業の財務・戦略的SWOT分析
    Summary Dawnrays Pharmaceutical (Holdings) Ltd (Dawnrays) is a manufacturer of cephalosporin antibiotics and specific medicines. The company provides products such as cefoperazone sodium and sulbactam sodium sterile, cefoperazone sodium sterile, ceftazidime sterile, cefixme, ceftriaxone sodium crude …
  • A-Cap Energy Ltd (ACB):企業の財務・戦略的SWOT分析
    Summary A-Cap Energy Ltd (A-Cap) is a mineral resources development company that acquires, explores, and develops mineral resource properties across Australia. It explores for coal and uranium deposits. Its projects include Letlhakane uranium project, the Mea coal project, and Foley coal project. A- …
  • Cheniere Energy Inc (LNG):企業の財務・戦略的SWOT分析
    Cheniere Energy Inc (LNG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Nissan Motor Co., Ltd.:企業の戦略・SWOT・財務分析
    Nissan Motor Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nissan Motor Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Saferoad Holding ASA (SAFE):企業の財務・戦略的SWOT分析
    Saferoad Holding ASA (SAFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Cox & Kings Limited
    Cox & Kings Limited - Strategy, SWOT and Corporate Finance Report Summary Cox & Kings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • NuVasive Inc (NUVA)-医療機器分野:企業M&A・提携分析
    Summary NuVasive Inc (NuVasive) is a medical device company that provides minimally invasive, procedurally-integrated spine solutions. The company principally provides Maximum Access Surgery (MAS), a minimally-disruptive surgical platform. MAS platform enables surgeons to perform a range of minimall …
  • Lixil Group Corporation (5938):企業の財務・戦略的SWOT分析
    Lixil Group Corporation (5938) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • AB Science SA (AB):企業の財務・戦略的SWOT分析
    Summary AB Science SA (ABS) is a pharmaceutical company focused on discovery, development, and commercialization of protein kinase inhibitors. The company's lead compound Masitinib, is a orally administered tyrosine kinase inhibitor targeting mast cells and selected kinases, including c-Kit, PDGFR, …
  • Verathon Inc:企業の戦略的SWOT分析
    Verathon Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • RF Surgical Systems Inc-医療機器分野:企業M&A・提携分析
    Summary RF Surgical Systems Inc (RF Surgical Systems), a subsidiary of Medtronic Plc is a medical equipment company that provides retained surgical sponge detection system. The company’s products include RF assure delivery system, RF assure detection system X, and RFDETECT premium. Its RF assures de …
  • Blue Dolphin Energy Company (BDCO):石油・ガス:M&Aディール及び事業提携情報
    Summary Blue Dolphin Energy Company (Blue Dolphin) is an oil and gas company that refines and markets petroleum products. The company own and operate pipeline assets and have leasehold interests in oil and gas properties. It also acquires, develops and explores oil and gas properties. Blue Dolphin o …
  • Taisho Pharmaceutical Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Taisho Pharmaceutical Co Ltd (Taisho), a subsidiary of Taisho Pharmaceutical Holdings Co Ltd is a pharmaceutical company that develops, manufactures and markets a range of prescription pharmaceutical and self-medication drugs. The company offers products such as lipovitan D, riup, clarith, z …
  • Steatite Limited:企業の戦略・SWOT・財務情報
    Steatite Limited - Strategy, SWOT and Corporate Finance Report Summary Steatite Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Public Joint-Stock Company Commercial Bank Privatbank:企業の戦略・SWOT・財務分析
    Public Joint-Stock Company Commercial Bank Privatbank - Strategy, SWOT and Corporate Finance Report Summary Public Joint-Stock Company Commercial Bank Privatbank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆